Latest News & Updates
Breaking News
4 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Glenmark Pharma Launches Vancomycin Injection in U.S. Following Bioequivalence Clearance Against Fresenius Kabi Reference
Glenmark Pharma enters U.S. injectable generics with Vancomycin, bioequivalent to Fresenius Kabi's reference listed drug.
Pharma Now Editorial Team
Boehringer Ingelheim Gains Japan MHLW Approval for Nerandomilast in IPF and PPF
Japan's MHLW approves nerandomilast for IPF and PPF, making Japan the fourth market to clear Boehringer Ingelheim's PDE4B inhibitor.
Pharma Now Editorial Team
Solara Active Pharma Secures FY26 Revenue Recovery but Ibuprofen Unit Posts Negative EBITDA
Solara's ibuprofen unit posted negative EBITDA of Rs. 179M in Q4 despite 61% revenue growth, triggering a formal strategic review.
Pharma Now Editorial Team
Gland Pharma Posts Record Q4 FY26 Revenue as CDMO Injectable Demand Accelerates
Gland Pharma reports record Q4 FY26 revenue and near-doubled profit, with a 38% adjusted EBITDA margin driven by CDMO injectable segment growth.
Pharma Now Editorial Team
